J&J Increases Alza Ante By $5 Bil. Over Abbott: Concerta Has J&J Upbeat

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet